首页 > 最新文献

Revue Medicale de Bruxelles最新文献

英文 中文
Complex Regional Pain Syndrome in children and adolescents 儿童和青少年的复杂局部疼痛综合征
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-056
C. Richard, C. Fonteyne
{"title":"Complex Regional Pain Syndrome in children and adolescents","authors":"C. Richard, C. Fonteyne","doi":"10.30637/2022.21-056","DOIUrl":"https://doi.org/10.30637/2022.21-056","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of inhaled methoxyflurane in the management of shoulder dislocation in the emergency department 吸入甲氧基氟醚在急诊科肩关节脱位治疗中的作用
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-060
L. Troppmann, J. Cavenaile
{"title":"Contribution of inhaled methoxyflurane in the management of shoulder dislocation in the emergency department","authors":"L. Troppmann, J. Cavenaile","doi":"10.30637/2022.21-060","DOIUrl":"https://doi.org/10.30637/2022.21-060","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary incontinence determinants and risk factors in adolescents and young women in democratic republic of Congo 刚果民主共和国青少年和年轻妇女尿失禁的决定因素和危险因素
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-070
J. Nako Iyongo, A. Punga Maole Mongalembe, A. Nkodila Natuhoyila, JP Esika Mokumo, T. Mosolongo, M. Loposso Nkumu
{"title":"Urinary incontinence determinants and risk factors in adolescents and young women in democratic republic of Congo","authors":"J. Nako Iyongo, A. Punga Maole Mongalembe, A. Nkodila Natuhoyila, JP Esika Mokumo, T. Mosolongo, M. Loposso Nkumu","doi":"10.30637/2022.21-070","DOIUrl":"https://doi.org/10.30637/2022.21-070","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Risk of undernutrition and proven undernutrition: update of the diagnostic criteria 营养不良和已证实营养不良的风险:更新诊断标准
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-082
J. Preiser, S. Farine
{"title":"Risk of undernutrition and proven undernutrition: update of the diagnostic criteria","authors":"J. Preiser, S. Farine","doi":"10.30637/2022.21-082","DOIUrl":"https://doi.org/10.30637/2022.21-082","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BIJUVA®, the only bioidentical HRT, combining estradiol and progesterone in a single pill : finally available in Belgium, after the USA (approval in 2018 by the Food and Drug Administration) ! BIJUVA®,唯一的生物同质激素替代疗法,将雌二醇和黄体酮结合在一颗药丸中:终于在比利时上市,仅次于美国(2018年获得美国食品和药物管理局批准)!
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.22-042
M. L'Hermitte
{"title":"BIJUVA®, the only bioidentical HRT, combining estradiol and progesterone in a single pill : finally available in Belgium, after the USA (approval in 2018 by the Food and Drug Administration) !","authors":"M. L'Hermitte","doi":"10.30637/2022.22-042","DOIUrl":"https://doi.org/10.30637/2022.22-042","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
When pediatric psychiatry and genetics tangle: Psychiatric consequences of an unbalanced phenylketonuria during childhood and genetic regard 当儿科精神病学和遗传学纠缠:儿童时期苯丙酮尿不平衡的精神后果和遗传学方面
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-012
O. Van Ormelingen, S. Marchini, M. Delhaye
{"title":"When pediatric psychiatry and genetics tangle: Psychiatric consequences of an unbalanced phenylketonuria during childhood and genetic regard","authors":"O. Van Ormelingen, S. Marchini, M. Delhaye","doi":"10.30637/2022.21-012","DOIUrl":"https://doi.org/10.30637/2022.21-012","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indication for neutralizing monoclonal antibodies for treatment of COVID-19 in real life: the big gap with controlled randomized trials 中和单克隆抗体在现实生活中治疗COVID-19的适应症:与对照随机试验的巨大差距
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.22-043
M. Hildebrand, J. Goffard
Anti-SARS-CoV-2 neutralizing monoclonal antibodies treatments have been studied through randomized controlled trials and have demonstrated efficacy for prevention and early COVID-19 treatment. Their use in real life is different from studies in many points. Variant changes, vaccination coverage, treated groups with nAbs which are different from clinical trials are topics discussed in this paper.
通过随机对照试验研究了抗sars - cov -2中和单克隆抗体治疗方法,并证明了预防和早期治疗COVID-19的有效性。它们在现实生活中的应用在许多方面与研究不同。变异变化、疫苗接种覆盖率、与临床试验不同的nab治疗组是本文讨论的主题。
{"title":"Indication for neutralizing monoclonal antibodies for treatment of COVID-19 in real life: the big gap with controlled randomized trials","authors":"M. Hildebrand, J. Goffard","doi":"10.30637/2022.22-043","DOIUrl":"https://doi.org/10.30637/2022.22-043","url":null,"abstract":"Anti-SARS-CoV-2 neutralizing monoclonal antibodies treatments have been studied through randomized controlled trials and have demonstrated efficacy for prevention and early COVID-19 treatment. Their use in real life is different from studies in many points. Variant changes, vaccination coverage, treated groups with nAbs which are different from clinical trials are topics discussed in this paper.","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benign non cancereous disease and radiotherapy : current indications in 2021 良性非癌性疾病和放疗:2021年的当前适应症
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.20-098
P. van Houtte, M. Roelandts, P. Martinive, B. Donneaux, D. Van Gestel
{"title":"Benign non cancereous disease and radiotherapy : current indications in 2021","authors":"P. van Houtte, M. Roelandts, P. Martinive, B. Donneaux, D. Van Gestel","doi":"10.30637/2022.20-098","DOIUrl":"https://doi.org/10.30637/2022.20-098","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosai-Dorfman disease with lymph node, bone, and kidney involvement Rosai-Dorfman病伴淋巴结、骨和肾脏受累
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.21-043
I. Chabchoub, C. Dammak, M. Snoussi, I. Maaloul, R. Kallel, D. Chebbi, F. Frikha, Z. Bahloul
{"title":"Rosai-Dorfman disease with lymph node, bone, and kidney involvement","authors":"I. Chabchoub, C. Dammak, M. Snoussi, I. Maaloul, R. Kallel, D. Chebbi, F. Frikha, Z. Bahloul","doi":"10.30637/2022.21-043","DOIUrl":"https://doi.org/10.30637/2022.21-043","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rybelsus® (semaglutide) : the oral treatment of type 2 diabetes by a GLP-1 receptor agonist becomes reality ! Rybelsus®(semaglutide): GLP-1受体激动剂口服治疗2型糖尿病成为现实!
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.30637/2022.22-015
L. Crenier
{"title":"Rybelsus® (semaglutide) : the oral treatment of type 2 diabetes by a GLP-1 receptor agonist becomes reality !","authors":"L. Crenier","doi":"10.30637/2022.22-015","DOIUrl":"https://doi.org/10.30637/2022.22-015","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revue Medicale de Bruxelles
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1